US FDA Should Explain How It Uses Patient Experience Data In Drug Approvals – Report

Review documents do not always reflect whether PED was considered as part of an application, and stakeholders cannot easily determine how such data are used in the agency’s regulatory decision-making, an independent consultant review found.